Fig. 1
From: Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer
The expression of IL17A between normal and HNSCC tumor tissues (A). Kaplan–Meier survival curves comparing the high and low expression of IL17A in HNSCC patients (B). Multivariate Cox analysis of IL17A expression and other clinicopathological variables (C). IL17A expression distribution and survival status (D, 0, Alive; 1, dead). Expression of IL17A significantly correlated with over survival status (E), clinical T stage (F) and lymphovascular invasion (G). *p < 0.05, **p < 0.01, ***p < 0.005